E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2007 in the Prospect News Special Situations Daily.

Quantum Partners sells shares of NPS Pharmaceuticals, keeps 1.75% stake

By Jennifer Chiou

New York, Oct. 5 - NPS Pharmaceuticals, Inc. investors led by Quantum Partners LDC sold shares of the company's stock between Oct. 2 and Oct. 5, priced from $5.45 to $5.6356.

Following the trades, the reporting persons beneficially own 809,230 shares, or 1.75%, of the Parsippany, N.J. biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.